Amarin Corporation Plc Sponsored ADR(NASDAQ : AMRN)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| VRX | Valeant Pharmaceuticals International, Inc. | 0.33% | 24.72 | 14.1% | $219.73m | |
| SHPG | Shire PLC Sponsored ADR | 1.12% | 162.40 | 0.4% | $164.90m | |
| JAZZ | Jazz Pharmaceuticals Plc | -1.67% | 180.13 | 2.2% | $100.54m | |
| SAGE | SAGE Therapeutics, Inc. | -2.25% | 161.24 | 9.6% | $88.75m | |
| PRGO | Perrigo Co. Plc | -0.65% | 75.37 | 6.7% | $87.33m | |
| ENDP | Endo International Plc | -1.38% | 9.30 | 8.9% | $76.58m | |
| ICPT | Intercept Pharmaceuticals, Inc. | -1.19% | 84.11 | 21.8% | $54.37m | |
| GWPH | GW Pharmaceuticals PLC Sponsored ADR | -1.00% | 151.01 | 7.6% | $52.90m | |
| MNK | Mallinckrodt Plc | -3.67% | 19.45 | 21.1% | $50.60m | |
| PTLA | Portola Pharmaceuticals, Inc. | -2.51% | 41.99 | 7.7% | $47.13m | |
| SUPN | Supernus Pharmaceuticals, Inc. | 0.52% | 58.35 | 6.3% | $41.99m | |
| UTHR | United Therapeutics Corporation | -1.34% | 116.73 | 14.4% | $35.91m | |
| HZNP | Horizon Pharma plc | -1.07% | 17.63 | 7.5% | $33.77m | |
| CTLT | Catalent Inc | -1.62% | 41.83 | 2.6% | $32.28m | |
| AERI | Aerie Pharmaceuticals, Inc. | 2.20% | 67.35 | 7.9% | $30.87m |
Company Profile
Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It's product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.